BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 25989227)

  • 1. Developmental trajectories in 22q11.2 deletion.
    Swillen A; McDonald-McGinn D
    Am J Med Genet C Semin Med Genet; 2015 Jun; 169(2):172-81. PubMed ID: 25989227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome.
    Tang KL; Antshel KM; Fremont WP; Kates WR
    J Dev Behav Pediatr; 2015 Oct; 36(8):639-50. PubMed ID: 26372046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
    Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
    BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental coordination disorder, psychopathology and IQ in 22q11.2 deletion syndrome.
    Cunningham AC; Delport S; Cumines W; Busse M; Linden DEJ; Hall J; Owen MJ; van den Bree MBM
    Br J Psychiatry; 2018 Jan; 212(1):27-33. PubMed ID: 29433607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
    Schneider M; Debbané M; Bassett AS; Chow EW; Fung WL; van den Bree M; Owen M; Murphy KC; Niarchou M; Kates WR; Antshel KM; Fremont W; McDonald-McGinn DM; Gur RE; Zackai EH; Vorstman J; Duijff SN; Klaassen PW; Swillen A; Gothelf D; Green T; Weizman A; Van Amelsvoort T; Evers L; Boot E; Shashi V; Hooper SR; Bearden CE; Jalbrzikowski M; Armando M; Vicari S; Murphy DG; Ousley O; Campbell LE; Simon TJ; Eliez S;
    Am J Psychiatry; 2014 Jun; 171(6):627-39. PubMed ID: 24577245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical language characteristics and trajectories in children with 22q11.2 deletion syndrome.
    Van Den Heuvel E; Manders E; Swillen A; Zink I
    J Commun Disord; 2018; 75():37-56. PubMed ID: 30005318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?
    Demily C; Franck N
    Eur J Med Genet; 2016 Nov; 59(11):596-603. PubMed ID: 27639442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 22q11.2DS deletion syndrome: developmental milestones in infants and toddlers.
    Roizen NJ; Antshel KM; Fremont W; AbdulSabur N; Higgins AM; Shprintzen RJ; Kates WR
    J Dev Behav Pediatr; 2007 Apr; 28(2):119-24. PubMed ID: 17435462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microdeletion 22q11: apropos of case of schizophrenia in an adolescent].
    Pinquier C; Héron D; de Carvalho W; Lazar G; Mazet P; Cohen D
    Encephale; 2001; 27(1):45-50. PubMed ID: 11294038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in speech and language abilities between children with 22q11.2 deletion syndrome and children with phenotypic features of 22q11.2 deletion syndrome but without microdeletion.
    Rakonjac M; Cuturilo G; Stevanovic M; Jelicic L; Subotic M; Jovanovic I; Drakulic D
    Res Dev Disabil; 2016 Aug; 55():322-9. PubMed ID: 27235769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in Neuropsychological Phenotypes in Patients with 22Q11.2 Deletion Syndrome: Case Series.
    Wierzchowski A; Sablich-Duley S; Bordes Edgar V
    Dev Neuropsychol; 2021 Aug; 46(5):381-392. PubMed ID: 34311629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits in childhood, adolescence and adulthood in 22q11.2 deletion syndrome and association with psychopathology.
    Morrison S; Chawner SJRA; van Amelsvoort TAMJ; Swillen A; Vingerhoets C; Vergaelen E; Linden DEJ; Linden S; Owen MJ; van den Bree MBM
    Transl Psychiatry; 2020 Feb; 10(1):53. PubMed ID: 32066691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.
    Niarchou M; Chawner SJRA; Fiksinski A; Vorstman JAS; Maeder J; Schneider M; Eliez S; Armando M; Pontillo M; Vicari S; McDonald-McGinn DM; Emanuel BS; Zackai EH; Bearden CE; Shashi V; Hooper SR; Owen MJ; Gur RE; Wray NR; van den Bree MBM; Thapar A;
    Schizophr Res; 2019 Feb; 204():320-325. PubMed ID: 30093352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using kinematic analyses to explore sensorimotor control impairments in children with 22q11.2 deletion syndrome.
    Cunningham AC; Hill L; Mon-Williams M; Peall KJ; Linden DEJ; Hall J; Owen MJ; van den Bree MBM
    J Neurodev Disord; 2019 Jun; 11(1):8. PubMed ID: 31182009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome.
    Niarchou M; Martin J; Thapar A; Owen MJ; van den Bree MB
    Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):730-8. PubMed ID: 26400629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.